We’ve reached millions of Nigerian women and children since 1978.
- Jhpiego-trained skilled birth attendants supervised more than 2.3 million antenatal care visits and 533,000 institutional deliveries.
- More than 190,000 pregnant women were reached with HIV prevention messages, counseling and testing; of women identified as HIV-positive, 99% received appropriate antiretrovirals.
- Jhpiego’s technical assistance has resulted in development of up-to-date national guidelines on HIV testing services to permit recency testing and other novel case-finding approaches, including HIV self-testing, partner notification services (index testing) and dual HIV/syphilis rapid diagnostic testing.
- Jhpiego pioneered an approach to link community-based volunteers with health centers to address malaria in pregnancy in Akwa Ibom State, increasing the percentage of women taking two doses of sulfadoxine-pyrimethamine for malaria prevention by 66%.
Our Work in Nigeria
Jhpiego serves as a core partner on the Palladium-led Integrated Health Program, the U.S. Agency for International Development’s main program for primary health care (PHC) in Nigeria. The overall objectives are to strengthen systems supporting PHC services, improve access to PHC services and increase the quality of PHC services. The program is expected to contribute to reductions in child and maternal morbidity and mortality in up to five target states, and to increase the capacity of health systems (public and private) to sustainably support high-quality PHC services. Jhpiego’s role is to provide technical leadership in the following areas: maternal and newborn health, including community-based interventions; family planning/reproductive health; quality improvement and use of data for decision-making; supportive supervision; clinical mentoring and training; and community-facility referral/linkages.
Under this Unitaid-funded, five-year grant, Jhpiego is partnering with ISGlobal to reduce maternal and neonatal mortality in the Democratic Republic of Congo, Nigeria, Madagascar and Mozambique by: 1) introducing and setting the stage for scale-up of community intermittent preventive treatment of malaria in pregnancy (IPTp); 2) introducing and increasing demand for quality-assured sulfadoxine-pyrimethamine (SP) for IPTp; and 3) generating evidence for World Health Organization policy change. To achieve desired results, Jhpiego is also collaborating with Medicines for Malaria Venture (to bring quality-assured SP to market) and the World Health Organization (to ensure SP resistance monitoring and foster collaboration between national reproductive health programs and national malaria control programs). For more information, visit here: www.tiptopmalaria.org.
This two-year project, funded by Merck for Mothers (MSD), aims to reduce maternal mortality from indirect causes. Jhpiego is applying an innovative quality of care model to improve prevention, early detection and management of indirect causes of maternal mortality and morbidity along the continuum of public and private maternal and reproductive health care services. The model reduces fragmentation and strengthens linkages for a more effective continuum of care across the life cycle (pre-pregnancy, pregnancy and postnatal) and across health system levels (primary, hospital and specialty).
This four-year project, funded by the Bill & Melinda Gates Foundation, builds on the PMA2020 project, which used innovative mobile technology to support low-cost, rapid-turnaround surveys monitoring key health and development indicators. PMA is enhancing this survey platform to generate high-quality data and ensure that governments, donors, managers and advocates use this data to make decisions regarding family planning programs. In addition to scaling up the survey platform for more widespread use, this project supports expanding it to include additional technical areas. Co-led by Jhpiego and the Bill & Melinda Gates Institute for Population and Reproductive Health, this project is operational in several African and Asian countries, including Nigeria.